ASHOK KOMARLA: Open Payments
NPI 1790882439 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 12 payments from 6 companies in 2025. Trend: 2023 $364 · 2024 $679 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $65 |
| ABBVIE INC. | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Janssen Pharmaceuticals, Inc | 1 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
Products named: VRAYLAR, COBENFY, ABILIFY ASIMTUFII, LYBALVI, INVEGA SUSTENNA, INGREZZA, ARISTADA.
Industry payments across FL — which companies pay providers there.
